| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $103.8M | -7.7% |
| SG&A Expense | $37.7M | +14.3% |
| Operating Income | -$141.5M | +42.8% |
| Net Income | -$125.0M | +48.5% |
| EPS (Basic) | -$0.83 | +58.3% |
| EPS (Diluted) | -$0.83 | +58.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $93.1M | -67.3% |
| Short-term Investments | $219.3M | +44.8% |
| Current Assets | $320.7M | -27.9% |
| Total Assets | $395.3M | -23.2% |
| Current Liabilities | $26.2M | -46.3% |
| Total Liabilities | $78.6M | -23.7% |
| Stockholders' Equity | $316.7M | -23.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$101.2M | +2.0% |
| Capital Expenditures | $1.8M | -87.8% |
| Investing Cash Flow | -$91.2M | -28.3% |
| Financing Cash Flow | $1.3M | -98.7% |
| Free Cash Flow | -$103.0M | +12.6% |